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Interrogation of the infarcted and 
salvaged myocardium using multi-
parametric mapping cardiovascular 
magnetic resonance in reperfused 
st-segment elevation myocardial 
infarction patients
Derek J. Hausenloy1,2,3,5,7,8, Mei Xing Lim5,7, Mervyn H. H. Chan5,7, Valeria paradies5, 
Rohin Francis1,4, Tushar Kotecha4, Daniel S. Knight4, Marianna Fontana4, Peter Kellman6, 
James C. Moon2,3 & Heerajnarain Bulluck  1,9
We used multi-parametric cardiovascular magnetic resonance (CMR) mapping to interrogate the 
myocardium following ST-segment elevation myocardial infarction (STEMI). Forty-eight STEMI patients 
underwent CMR at 4 ± 2 days. One matching short-axis slice of native T1 map, T2 map, late gadolinium 
enhancement (LGE), and automated extracellular volume fraction (ECV) maps per patient were 
analyzed. Manual regions-of-interest were drawn within the infarcted, the salvaged and the remote 
myocardium. A subgroup analysis was performed in those without MVO and with ≤75% transmural 
extent of infarct. For the whole cohort, T1, T2 and ECV in both the infarcted and the salvaged 
myocardium were significantly higher than in the remote myocardium. T1 and T2 could not differentiate 
between the salvaged and the infarcted myocardium, but ECV was significantly higher in the latter. 
In the subgroup analysis of 15 patients, similar findings were observed for T1 and T2. However, there 
was only a trend towards ECVsalvage being higher than ECVremote. In the clinical setting, current native T1 
and T2 methods with the specific voxel sizes at 1.5 T could not differentiate between the infarcted and 
salvaged myocardium, whereas ECV could differentiate between the two. ECV was also higher in the 
salvaged myocardium when compared to the remote myocardium.
Myocardial salvage index (MSI) is considered a more sensitive measure for assessing the efficacy of a cardiopro-
tective strategy than an absolute reduction in myocardial infarct (MI) size, as it normalizes the reduction in MI 
size to the area-at-risk (AAR)1–3. The AAR refers to the territory supplied by the infarct-related artery that would 
have been irreversibly injured without reperfusion. Once the AAR and MI size are known, MSI can be calculated 
using the formula: myocardial salvage index = (AAR − MI size)/AAR4.
Cardiovascular magnetic resonance imaging (CMR) is considered the reference standard technique for MI 
size quantification5–7. It can also provide information on the edema-based AAR using T2-weighted imaging3,8,9, 
T2 mapping10,11, T1 mapping11,12, early gadolinium enhancement13, or post-contrast steady-state-free-precession 
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(SSFP) cine images14. However, none of these techniques have been established as the reference standard in the 
clinical setting for the AAR by CMR. Controversies exist on whether edema is confined to the infarcted myocar-
dium only15, or extends to the salvaged myocardium16.
Conventionally, MI size is quantified on the late gadolinium enhancement (LGE) imaging following contrast 
administration4. Native T1 and T2 mappings are acquired prior to contrast administration. A recent pre-clinical 
study16 using a canine model of reperfused MI has reported that native T2 values were higher in infarcted myo-
cardium when compared to salvaged myocardium. However, the same group reported no difference in native T1 
values between the infarcted and salvaged myocardium, but post-contrast T1 was able to differentiate between the 
infarcted and salvaged myocardium, 8 minutes following contrast injection17. So far, no clinical studies have inter-
rogated the infarcted and salvaged myocardium in the same patients using the latest T1, T2 and ECV mapping 
technology. If we were able to differentiate between the infarcted and salvaged myocardium using native T1 and 
T2 mapping, we could potential quantify both the AAR and MI size accurately without contrast on these maps 
by applying different thresholds, which would significantly shorten scan time for these patients and expand the 
availability to those with contraindications to the gadolinium chelate.
In order to clarify whether the infarcted myocardium can be distinguished from the salvaged myocardium 
in the acute setting, we used multiparametric CMR with native T1 maps, T2 maps and automated extracellular 
volume fraction (ECV) mapping to interrogate the infarcted and salvaged myocardium in patients shortly after 
ST-segment elevation myocardial infarction (STEMI) reperfused by primary percutaneous coronary intervention 
(PPCI).
Materials and Methods
study population. Patients included in this study have been previously reported18–25 but no prior publi-
cations have addressed multiparametric mapping in the salvaged and the infarcted myocardium. In brief, the 
London-Harrow Research Ethics Committee approved this study. Fifty STEMI patients were prospectively 
recruited from August 2013 to July 2014 following informed consent. This study complied with the declaration of 
Helsinki and was approved by the local ethics committee. Forty-eight patients completed the first CMR at 4 ± 2 
days post-PPCI. A subgroup analysis was performed in those patients without late microvascular obstruction 
(MVO) (as this would interfere with the T1 and T2 of the infarcted myocardium) and with ≤75% transmural 
extent of infarct (to minimize partial volume effects when drawing the regions of interest (ROI) in the salvaged 
myocardium).
Cardiac MRI acquisition. All CMR scans were performed on a 1.5 Tesla scanner (Magnetom Avanto, 
Siemens Medical Solutions) using a 32-channel phased-array cardiac coil. The imaging protocol included short 
axis coverage of cines, native Modified Look-Locker Inversion Recovery (MOLLI) T1 mapping, T2 mapping, 
LGE and post-contrast T1 mapping. All the short axis images were aligned with the cine short axis slice position.
Native T1 mapping (Work in progress 448B, siemens healthcare). An SSFP-based MOLLI sequence 
with a sampling protocol of 5 s(3 s)3 s was used for the T1 maps. The acquisition parameters were: flip angle = 35°; 
pixel bandwidth 977 Hz/pixel; matrix = 256 × 144; echo time = 1.1 ms; voxel size = 1.5 × 2.0 × 6.0 mm. Motion 
correction and a non-linear least-square curve fitting of the set of images acquired at different inversion times 
were performed inline by the scanner to generate a pixel-wise colored T1 map26.
T2 Mapping (Work in progress 448B, siemens healthcare). Pixel-wise colored T2 maps were gener-
ated inline following motion correction and fitting to estimate T2 relaxation times27 after acquiring 3 single-shot 
images at different T2 preparation times (0 ms, 24 ms, and 55 ms, respectively) and the acquisition parame-
ters were: flip angle = 70°; pixel bandwidth 930 Hz/pixel; matrix = 116 × 192; echo time = 1.1 ms; repetition 
time = 3xR-R interval; voxel size = 2.0 × 2.7 × 6.0 mm.
Late gadolinium enhancement. LGE images were acquired 10 to 15 minutes after the injection of 
0.1 mmol/kg of Gadoterate meglumine (Gd-DOTA marketed as Dotarem, Guerbet S.A., Paris, France), using 
either a standard segmented ‘fast low-angle shot’ two-dimensional inversion-recovery gradient echo sequence 
LGE phase-sensitive inversion recovery (PSIR) sequence or a respiratory motion-corrected, free-breathing 
single-shot SSFP averaged PSIR sequence28.
Post-contrast T1 mapping (Work in progress 448B, siemens healthcare). Post-contrast T1 maps 
were obtained using the 4 s(1 s)3 s(1 s)2 s sampling protocol (to improve the accuracy of T1s in the 200–600 ms 
range as previously described29) 15 minutes after contrast injection (0.1 mmol/kg of Dotarem) using similar 
acquisition parameters (voxel size = 1.5 × 2.0 × 6.0 mm) as for native T1 maps.
ECV mapping. The previously described and validated automated method for producing a pixel-wise ECV 
map was used30 with motion-correction and co-registration of the native and post-contrast T1 pixel maps. Each 
patient had hematocrit checked at the time of the scan and a pixel by pixel, re-motion corrected and re-registered 
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Imaging analysis. All imaging analysis was performed using CVI42 software (V.5.1.2 (303), Calgary, 
Canada) as previously described18,25. In brief, MI size (from LGE images) and AAR (from T2 maps) were quan-
tified from the whole LV coverage short axis acquisitions using signal intensity thresholds of 5 and 2 standard 
deviations (SD) above the normal remote myocardium32, respectively, and expressed both as a percentage of the 
left ventricle (%LV) and in grams. Transmural extent of infarct (TEI) was quantified by averaging the values from 
100 chords from each short axis slice to obtain the mean transmural extent of LGE for each of the 16 American 
Heart Association (AHA) segments and expressed in as a continuous variable and then objectively classified into 
groups of “no LGE”, “1–25%TEI”, “26–50%TEI”, “51–75% TEI” and “76–100%TEI25”.
For representative parametric data in the infarcted, salvaged and remote myocardium for each patient, one 
short-axis slice per patient of matching native T1 map, T2 map, ECV map through the region of wall motion 
abnormality was analyzed and the corresponding LGE image was used as the reference. ROIs were manually 
delineated in the infarcted, salvaged and the remote myocardium as shown in Fig. 1. ROI delineation in the 
infarcted and salvaged myocardium were performed using a similar approach to a previous study (infarcted myo-
cardium identified as the region of hyperenhancement on LGE images while salvaged myocardium identified as 
the non-enhancing myocardium epicardial to the infarcted myocardium)16. After identifying the infarcted and 
salvaged myocardium on LGE, ROIs were placed in the corresponding regions on the native T1 maps and copied 
to the T2 and ECV maps, with minimal manual adjustments when required to avoid partial volume effects. The 
remote myocardium was defined as the region that did not display any LGE, native T1 or T2 abnormalities in a 
segment that was 180° from the infarct-related territory. In those with >75%TEI, no ROI were available for the 
salvaged myocardium. Patients without MVO (to avoid the interference of the hypointense core on the T1 and T2 
values of the infarcted myocardium) and with ≤75%TEI (to minimize partial volume effects when drawing ROI 
in the salvaged myocardium) were included in the subgroup analysis. In order to evaluate whether partial volume 
effect may impact on our results, we also excluded those patients with TEI 51–75% in a further subgroup analysis.
statistical analysis. Statistical analysis was performed using SPSS version 22 (IBM Corporation, IL). 
Normality was assessed using Shapiro-Wilk test. Continuous data were expressed as mean ± SD or median (inter-
quartile range), and compared with the paired Student t-test/Wilcoxon signed rank test or unpaired Student t 
test/Mann–Whitney U test, where appropriate. Categorical data were reported as frequencies and percentages. 
To compare T1, T2 and ECV values in the remote, salvaged and infarcted myocardium, a linear mixed model was 
used with the T1, T2 or ECV being the dependent variable; the patients being a covariate; and the territory within 
patients (remote, salvaged, infarcted) being a fixed factor, to take into account interaction among segments within 
the same patients. Pairwise comparison was performed using Bonferroni correction. All statistical tests were 
2-tailed, and P < 0.05 was considered statistically significant.
Figure 1. Example of matching maps and LGE image per patient analyzed for this study. This is an example of 
the native T1, T2 and ECV maps for a patient with an acute inferior STEMI. Using the LGE image as reference, 
manual ROIs were drawn in infarcted (No. 1), salvaged (No. 2) and remote myocardium (No. 3) on the native 
T1, T2 and ECV maps.
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Results
Baseline characteristics of the patients are shown in Table 1. CMR was performed at 4 ± 2 days. The median age 
of the patients was 60 (49–69) years old and the majority of patients (40/48, 83%) were male. The infarct-related 
coronary artery distribution was as follows: left anterior descending artery in 28/48 (58%) of patients; right coro-
nary artery in 18/48 (38%); and circumflex artery in 2/48 (4%), (Table 1).
403/768 (53%) myocardial segments had no LGE. Out of those segments with LGE, the TEI were as follows: 
1–25%TEI: 89/365 (24%); 26–50%TEI: 100/365 (27%); 51–75% TEI: 90/365 (25%); and 76–100%TEI: 86/365 
(24%). 15 patients without MVO and with ≤75%TEI were included in the subgroup analysis (Table 1).
Whole cohort (n = 48). T1infarct (1253 ± 73 ms) and T1salvage (1219 ± 66 ms) were both higher than T1remote 
(1033 ± 53 ms, P < 0.001 for both) with no significant difference between T1infarct and T1salvage (P = 0.15) (Fig. 2).
T2infarct (66 ± 6 ms) and T2salvage (64 ± 6 ms) were significantly higher than T2remote (50 ± 3 ms, P < 0.001 for 
both comparison) with no significant difference between T2infarct and T2salvage (P = 0.42) (Fig. 3).
Details
Number
N = 48 (whole cohort) N = 15 (subgroup)
Number of patients 48 15
Male (%) 40 (83) 13 (87)
Age (year) 60 [49–69] 56 [42–67]
Diabetes Mellitus (%) 9 (19) 5 (33)
Hypertension (%) 15 (31) 3 (20)
Smoker (%) 15 (31) 6 (40)
Dyslipidemia (%) 15 (31) 5 (33)
LAD (%) 28 (58) 5 (33)
Cx (%) 2 (4) 1 (7)
RCA (%) 18 (38) 9 (60)
Onset-to-balloon time (mins) 182 [128–328] 178 [129–326]
MI size (%LV) 26 [18–38] 19 [10–28]
AAR (%LV) 43 [33–52] 39 [31–53]
MVO (%) 30 (63) 0
LV End-diastolic volume (ml) 162 [138–195] 152 [132–170]
LV End-systolic volume (ml) 81 [62–112] 67 [62–93]
LV Ejection fraction (%) 49 [43–58] 52 [46–59]
LV Mass (g) 113 [92–132] 120 [81–133]
Table 1. Patients’ baseline characteristics. The interquartile ranges for the medians are enclosed using the 
square brackets. LAD: left anterior descending artery; Cx: circumflex artery; RCA: right coronary artery; MI: 
myocardial infarct; AAR: area-at-risk; LV: left ventricle.
Figure 2. Comparison of native T1 values in the infarcted, salvaged and remote myocardium. This bar 
chart compares the native T1 values in the infarcted, salvaged and remote myocardium. Native T1 could not 
differentiate between the salvaged and the infarcted myocardium.
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ECVinfarct (70 ± 9%) was significantly higher than ECVsalvage (38 ± 4%) and ECVremote (28 ± 2%, P < 0.001 for 
both comparisons). Furthermore, ECVsalvage was also significantly higher than ECVremote (P < 0.001) (Fig. 4).
subgroup analysis (n = 15). A similar pattern was observed for T1 and T2 in the subgroup of patients 
without MVO and with ≤75%TEI. T1infarct (1283 ± 81 ms) and T1salvage (1235 ± 61 ms) were significantly higher 
than T1remote (993 ± 49 ms, P < 0.001) with no significant difference between T1infarct and T1salvage (P = 0.38).
T2infarct (64 ± 5 ms) and T2salvage (62 ± 7 ms) were significantly higher than T2remote (48 ± 3 ms, P < 0.001) and 
there was no significant difference between T2infarct and T2salvage (P = 0.45).
As for ECV, ECVinfarct (60 ± 10%) was significantly higher than ECVsalvage (37 ± 5%, P < 0.001) and ECVremote 
(24 ± 3%, P < 0.001). However, there was only a trend towards ECVsalvage being higher than ECVremote but this 
comparison did not reach statistical significance (P = 0.07).
In order to evaluate whether partial volume effect may have contributed to some extent to the above results, 
we further excluded those patients with TEI 51–75% (n = 3). The same findings were seen for T1 (T1infarct; 
1293 ± 86 ms; T1salvage: 1243 ± 63 ms; T1remote: 993 ± 54 ms), T2 (T2infarct; 64 ± 5 ms; T2salvage: 63 ± 7 ms; T2remote: 
48 ± 3 ms) and ECV (ECVinfarct; 61 ± 11%; ECVsalvage: 36 ± 5%; ECVremote: 24 ± 3%). There was no significant dif-
ference between T1infarct and T1salvage (P = 0.27) and between T2infarct and T2salvage (P = 0.99) but there was a signif-
icant difference between ECVinfarct and ECVsalvage (P = 0.001).
Figure 3. Comparison of T2 values in the infarcted, salvaged and remote myocardium. This bar chart compares 
the T2 values in the infarcted, salvaged and remote myocardium. T2 could not differentiate between the 
salvaged and the infarcted myocardium.
Figure 4. Comparison of ECV values in the infarcted, salvaged and remote myocardium. This bar chart 
compares the ECV values in the infarcted, salvaged and remote myocardium. ECV could differentiate between 
the salvaged and the infarcted myocardium.
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Discussion
This study shows that both infarcted and salvaged myocardium have elevated T1 and T2 but whilst the ECV was 
very elevated in infarction, it was partly elevated in salvage, with implications for salvage detection (T1 and T2 not 
useful alone), and for our understanding of salvage.
Although the standard deviation of the T1 in the remote myocardium appeared relatively high (±53 ms), we 
have previously reported reference values by MOLLI in a healthy control group to be 1000 ± 25 ms19. Therefore, 
the larger variability in T1 in the remote myocardium in this cohort is unlikely due to the precision of the T1 map-
ping technique used, but rather changes in the remote myocardium that us19 and other groups33,34 have reported 
upon previously.
Our results are consistent with the findings of previous studies showing that the increase in native T1 and T2 
values in the infarct-related artery corresponded to the edema-based AAR in the clinical setting10–12,35. The poten-
tial explanation for our observations could be related to the difference in severity of the intracellular and extracel-
lular edema in the infarcted and salvaged myocardium. Native T1 and T2 measure edema both in the intracellular 
and extracellular compartments, whereas ECV measures edema in the extracellular compartment only. Native 
T1 and T2 may be similarly affected by intracellular edema, and may not be able to differentiate the severity of 
extracellular edema in some patients. Following contrast administration, the kinetics of the gadolinium chelate 
wash-in and wash-out at pseudo-equilibrium would be different in the infarcted (likely to predominantly consist 
of cardiomyocytes with ruptured cell membranes and extracellular edema) and salvaged myocardium (likely to 
predominantly consist of cardiomyocytes with intact cell membrane and with both intracellular and extracellular 
edema). A larger concentration of contrast would be present in the infarcted myocardium than in the salvaged 
myocardium (guided by the severity of extracellular edema) and this would explain the difference in the findings 
between pre-contrast and post-contrast mapping parameters. It is not surprising that ECV was significantly dif-
ferent between the infarcted and salvaged myocardium and this likely reflects the different severity of extracellular 
edema in those two territories. In those with significant myocardial salvage, the extracellular edema may be less 
severe as shown by the ECV values in our subgroup analysis where there was some overlap between the salvaged 
and remote myocardium.
However, Hammer-Hansen et al.16 recently reported in a canine model of reperfused MI that T2 values in the 
infarcted myocardium were higher than in the salvaged myocardium, and both were significantly higher than 
the remote myocardium. They only included 11 animals, and they all underwent mid left anterior descending 
artery ligation for 2 hours, and CMR was performed at similar times for all animals. The difference between the 
pre-clinical and clinical findings may be related to the animal species used (canines being more prone to develop 
collaterals) or the heterogeneity of the patient selection (patients presenting with a wide duration of symptoms, 
with STEMI in all territories and with CMR performed at different time points post-PPCI). Furthermore, the 
occlusion of the infarct-related artery was abrupt in the animal model whether was this process is slower and 
stuttering in the clinical setting with downstream embolism of plaque debris and microemboli. Although we also 
performed a subgroup analysis by excluding patients with MVO (to avoid the interference of the hypointense 
core on the T1 and T2 values of the infarcted myocardium) and >75% TEI (to minimize partial volume effects 
when drawing ROI in the salvaged myocardium), some patients may still have had minute areas of MVO and 
haemorhage within the infarcted myocardium that were not visible to the naked eye and may have affected the 
native T1 and T2 values within the infarcted myocardium.
In the clinical setting, Hammer-Hansen et al.17 also showed that native T1 was similar in the infarcted and 
salvaged myocardium, and our findings confirm this. If T1 and T2 mapping could differentiate between infarcted 
and salvaged myocardium at 1.5 T in the acute setting, then by applying a particular threshold, it would possible 
to delineate the acute MI size without contrast. Interestingly, Liu et al.36 recently showed that native T1-mapping 
could identify acute MI size. However, their study was performed on a 3 T scanner and only 58 short-axis T1 
maps without microvascular obstruction were analyzed in that study36. Further work is required with a larger 
number of patients to evaluate whether native T1 mapping can delineate the acute MI size.
ECV mapping at pseudo-equilibrium provides pixelwise quantification of the ratio of the extracellular com-
partment to the total myocardial volume. Hwang et al.37 previously showed that a threshold of ECV >0.42 or 
0.44 could be used to quantify the extent of scars in the setting of chronic MI and hypertrophic cardiomyopathy. 
Our findings are consistent with those from Hammer-Hansen et al.17, who showed that the ECV of the infarcted 
myocardium was higher than that of the salvaged myocardium. They also showed that the ECV of the salvaged 
myocardium was higher than that of the remote myocardium. Most recently, Garg et al.38 showed that ECV 
maps could be used for the AAR and chronic MI size by applying different thresholds. However, the limits of 
agreement with the T2-derived AAR from the T2-weighted imaging were quite wide at ±10.4%39. Whether the 
wide limits of agreement in edema measures seen in the study by Garg et al.39 could be due to ECV not identi-
fying the edema-based AAR accurately in some patients with less severe extracellular edema, warrants further 
investigation.
Partial volume effects may have affected these results. Further analysis of those with TEI up to only 50% 
resulted in finding consistent with our prior findings. However, this does not necessarily suggest that partial 
volume effects along the slice direction are not important. Despite this, this highlights the fact that in the clinical 
setting, using current T1 and T2 mapping with the current voxel sizes at 1.5 T, salvaged myocardium cannot be 
differentiated from the infarcted myocardium.
Limitations. The number of patients included in our study was small and therefore any further in-depth 
analysis of any temporal trend, relationship with other predictors and indicators of myocardial injury (symptom 
duration, patency of infarct-related artery and cardiac enzymes) were not performed. However, a retrospective 
sample size calculation to detect a 25% difference between the infarcted and remote myocardium showed that the 
study was adequately powered. CMR was performed at different days within the first week post-STEMI and may 
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be a source of bias, given that edema has been recently shown to be dynamic40. Our delineation of the infarcted 
and salvaged myocardium was based on the concept of ‘wave-front phenomenon’ where the ischemic injury is 
thought to progress radially from the subendocardium to the epicardium with increasing duration of coronary 
occlusion41, and therefore the epicardial side of the infarcted myocardium was considered as salvaged myocar-
dium. This is the same definition used by Hammer-Hansen et al.16. We only analyzed one short axis slice of T1, 
T2 and ECV maps per patient although this is similar to previous studies16,17. The spatial resolution of T1, T2, and 
ECV maps were not the same.
Conclusion
In this cohort of STEMI patients, current native T1 and T2 methods with the specific voxel sizes at 1.5 T could not 
differentiate between the infarcted and salvaged myocardium, whereas ECV could differentiate between the two. 
ECV was also higher in the salvaged myocardium when compared to the remote myocardium. Whether this is 
due to a true pathophysiological observation or partial volume effect warrants further investigation.
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